Investigate / AME
Understand AMETEK INC/
Can acquisitions and operational initiatives sustain growth if cyclical end markets weaken or integration proves harder than expected?
Snapshot reviewed 2026-10-02. Source published 2026-08-04. No account needed.
AI-assisted synthesis of selected public filings, checked against the cited excerpts. Not a complete analysis.
This is a research starting point, not a buy/sell recommendation or a current valuation. New developments after these sources are not incorporated automatically.
Your research workspace / AME
Ask better questions. Keep the evidence.
Explore the available sources for AMETEK INC/, then keep what deserves another look.
01 Investor activity
Who reports owning AME?
3 tracked reported owners. Disclosures are delayed and may describe different quarters—not live holdings or stated motives.
02 Business evidence
Reported evidence
What does the company do?
AMETEK sells electronic instruments for process, power, industrial and aerospace markets, plus precision motion control, engineered medical components, thermal management and specialty metals.
Latticework interpretation
What could support the case?
If the Growth Model delivers earnings growth and cash generation across the business cycle, it could support returns on capital.
Latticework interpretation
What could break the case?
If served markets decline or grow less than expected, demand for AMETEK’s products and services could weaken its results.
03 Questions to investigate
Open saved takeaways →Read the full company brief
1. Understand the business
AMETEK sells electronic instruments for process, power, industrial and aerospace markets, plus precision motion control, engineered medical components, thermal management and specialty metals.
Source: Annual filing · business description ↗2. What the reported results show
Latest source: 10-Q, reporting period ended 2026-06-30. Selected reported US-GAAP/USD comparisons. The period and basis of each measure are shown separately; year-to-date cash flow is not a quarterly figure. Missing comparisons are collection gaps, not evidence that a company has no revenue or earnings.
| Measure | Current | Prior year |
|---|---|---|
| Revenue from customer contracts ↗Quarter: 2026-04-01–2026-06-30; prior 2025-04-01–2025-06-30Both values reported in the current filing. Excludes assessed tax; this concept may exclude other company revenue. | $2,044.397m | $1,778.056m |
| Operating income ↗Quarter: 2026-04-01–2026-06-30; prior 2025-04-01–2025-06-30Both values reported in the current filing. | $528.193m | $461.626m |
| Net income ↗Quarter: 2026-04-01–2026-06-30; prior 2025-04-01–2025-06-30Both values reported in the current filing. | $406.896m | $358.367m |
| Operating cash flow ↗Six months (year to date): 2026-01-01–2026-06-30; prior 2025-01-01–2025-06-30Both values reported in the current filing. Operating cash flow is not free cash flow or a standalone solvency assessment; inspect the full statement. | $935.21m | $776.634m |
3. The investment debate
Latticework interpretation of the reported results—not the stated motives of any investor.
What could support the case
If the Growth Model delivers earnings growth and cash generation across the business cycle, it could support returns on capital.
Supporting filing ↗The strongest caution
If served markets decline or grow less than expected, demand for AMETEK’s products and services could weaken its results.
Caution evidence ↗An interesting business is not necessarily an attractive investment at today's price. Price, dilution, financing terms and a valuation range still need investigation.
Inspect the evidence behind both sides ↗4. Three questions worth investigating
Use these to guide your research, not as conclusions that have already been proved.
How much of growth depends on acquisitions versus organic demand?
Starting evidence: Second-quarter sales growth was attributed to both organic increases and contributions from acquisitions, so their relative durability matters.
Investigate next: Compare organic versus acquired growth by segment across several periods in filings.
Read the supporting filing ↗How do recent acquisitions affect margins?
Starting evidence: Recent acquisitions and related integration costs diluted segment operating margins, while management reports improvement when those effects are excluded.
Investigate next: Review acquisition-related cost disclosures and margin commentary excluding acquisitions in upcoming filings.
Read the supporting filing ↗How exposed are results to tariffs and macro uncertainty?
Starting evidence: Management says tariff outcomes are uncertain and could adversely affect demand, costs, customers and suppliers, despite mitigation actions.
Investigate next: Examine tariff and supply-chain disclosures, plus sensitivity by region and end market.
Read the supporting filing ↗5. Decide what to do next
Worth another look? Save this company and return to the evidence. Writing a private view is optional. You do not need to decide whether to invest today.
Save is on this device. Recording a private view requires sign-in and an explicit save. Neither action subscribes you to email or automatically evaluates your thesis.